Detalhe da pesquisa
1.
Once-weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long-term cost-effectiveness analysis based on SUSTAIN 11.
Diabetes Obes Metab
; 25(2): 491-500, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251282
2.
An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg.
Diabetes Obes Metab
; 23(11): 2513-2520, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34286894
3.
The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK.
Eur J Health Econ
; 24(6): 895-907, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114904
4.
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal-Bolus Insulin in Type 2 Diabetes.
Diabetes Ther
; 14(1): 123-137, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36434159
5.
Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide.
J Med Econ
; 26(1): 1019-1031, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37525970
6.
Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting.
Pharmacoecon Open
; 6(3): 343-354, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064550
7.
Preference for Type 2 Diabetes Therapies in the United States: A Discrete Choice Experiment.
Adv Ther
; 39(9): 4114-4130, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35797004
8.
The long-term cost-effectiveness of oral semaglutide in the Netherlands based on the PIONEER 2, 3 and 4 randomized controlled trials.
Diabetes Res Clin Pract
; 175: 108759, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33744377
9.
Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis.
Diabetes Ther
; 12(5): 1325-1339, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33723769
10.
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK.
Adv Ther
; 37(5): 2427-2441, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306244
11.
Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK.
J Med Econ
; 23(1): 98-105, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31311364
12.
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme.
Diabetes Ther
; 11(1): 259-277, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833042
13.
The cost of needlestick injuries associated with insulin administration.
Br J Community Nurs
; 13(9): 413-7, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19024036
14.
Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting.
Diabetes Ther
; 9(5): 1919-1930, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30097995
15.
Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach.
Diabetes Metab Syndr Obes
; 11: 217-226, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29844693
16.
Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia.
Diabetes Ther
; 9(3): 1201-1216, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29700772
17.
Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus.
Diabetes Ther
; 8(2): 275-291, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28210866
18.
Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting.
Pharmacoeconomics
; 34(9): 953-66, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27438706
19.
Frequency of blood glucose testing among insulin-treated diabetes mellitus patients in the United Kingdom.
J Med Econ
; 17(3): 167-75, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24359593
20.
Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey.
J Med Econ
; 16(11): 1357-65, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24111563